BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8570083)

  • 21. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients.
    Shin J; Nishioka M; Shinko S; Shibuya K; Sugiki M; Kasumoto H; Fudo A; Bito Y; Fujita Y; Komaba K
    Ther Apher Dial; 2008 Feb; 12(1):62-6. PubMed ID: 18257814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carpal tunnel syndrome caused by amyloid containing beta 2 microglobulin: a new amyloid and a complication of long term haemodialysis.
    McClure J; Bartley CJ; Ackrill P
    Ann Rheum Dis; 1986 Dec; 45(12):1007-11. PubMed ID: 3545104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
    Nishi S
    Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carpal tunnel syndrome in patients undergoing CAPD: a collaborative study in 143 centers.
    Nomoto Y; Kawaguchi Y; Ohira S; Yuri T; Kubo H; Kubota M; Nihei H; Nakao T; Hara S; Nakamoto M
    Am J Nephrol; 1995; 15(4):295-9. PubMed ID: 7573186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients.
    Koda Y; Nishi S; Miyazaki S; Haginoshita S; Sakurabayashi T; Suzuki M; Sakai S; Yuasa Y; Hirasawa Y; Nishi T
    Kidney Int; 1997 Oct; 52(4):1096-101. PubMed ID: 9328951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteo-articular manifestations of amyloidosis.
    M'bappé P; Grateau G
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):459-75. PubMed ID: 23040361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The advanced glycation endproduct, pentosidine, in the carpal ligament in patients with carpal tunnel syndrome undergoing hemodialysis: comparison with idiopathic carpal tunnel syndrome.
    Takahashi M; Hoshino H; Kushida K; Murata H; Baba S; Inoue T
    Nephron; 1998 Dec; 80(4):444-9. PubMed ID: 9832644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis.
    van Ypersele de Strihou C; Jadoul M; Malghem J; Maldague B; Jamart J
    Kidney Int; 1991 May; 39(5):1012-9. PubMed ID: 2067196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using ultrapure water in hemodialysis delays carpal tunnel syndrome.
    Baz M; Durand C; Ragon A; Jaber K; Andrieu D; Merzouk T; Purgus R; Olmer M; Reynier JP; Berland Y
    Int J Artif Organs; 1991 Nov; 14(11):681-5. PubMed ID: 1757154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialysis-related amyloidosis: importance of biocompatibility and age.
    Jadoul M
    Nephrol Dial Transplant; 1998; 13 Suppl 7():61-4. PubMed ID: 9870440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
    Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho YJ; Wong MG; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Darssan D; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
    BMC Nephrol; 2018 Apr; 19(1):89. PubMed ID: 29665795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amyloidosis in hemodialysis patients].
    Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
    Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A clinical study of dialysis-related osteoarthropathy in long-term hemodialysis patients].
    Maruyama S
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):573-86. PubMed ID: 9893456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrences of carpal tunnel syndrome in long-term haemodialysis patients].
    Assmus H; Staub F
    Handchir Mikrochir Plast Chir; 2005 Jun; 37(3):158-66. PubMed ID: 15997426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study.
    Jadoul M; Garbar C; Noël H; Sennesael J; Vanholder R; Bernaert P; Rorive G; Hanique G; van Ypersele de Strihou C
    Kidney Int; 1997 Jun; 51(6):1928-32. PubMed ID: 9186884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study of dialyzers membranes.
    Macías Núñez JF; Ghais Z; Bustamante J; Lopez-Novoa JM; Arrieta J; Barril G; Del Pino MD; Escaja C; Martín IM; Fernández Andrade C; García F; Núñez J; Onaindía JM; González J; Pérez-Prieto M; Fernández M; Lopez J; Santiago JM; Vicens M; Sousa F
    Nephron Clin Pract; 2010; 114(1):c67-73. PubMed ID: 19816045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.